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Abstract: Aims and objectives. The goal of this study was to determine the impact of symptoms on the individual dimensions 
of the quality of life in patients with chronic obstructive pulmonary disease (COPD).
Background. The presence of symptoms or the fear of them in patients with COPD affects their physical and social activities. 
Actively combatting the disease depletes physical, emotional, and financial resources and affects the ability of the patient to 
overcome other life situations.
Methods. The sample consisted of 80 respondents with COPD, Stage II, as per GOLD classification. The average age of 
respondents was 62.9 years. The research was conducted using the Short Form Quality of Life Questionnaire (SF-36) and St. 
George’s Respiratory Questionnaire (SGRQ).
Results. Results of the SF-36 questionnaire indicated that the health-related quality of life was mostly limited: general health, 
physical functioning, vitality, and mental health. Next to the worsening of symptoms such as cough and dyspnoea, patients reported 
a worsening of the following dimensions: general health, physical functioning, bodily pain, vitality, social functioning, and mental 
health. A strong linear relationship was observed between the symptoms and the dimension limitation of emotional problems.
Relevance for clinical practice. The aim of a COPD comprehensive therapy should be to reduce its symptoms, preventing the 
loss of performance, improving daily activities, and in general improving the patient’s quality of life.
Key words: Chronic obstructive pulmonary disease, quality of life, respiratory physiotherapy.
INTRODUCTION
Lung diseases currently represent a serious prob-
lem worldwide for their high prevalence, morbidity 
and mortality, as well as a negative impact on the 
patient’s quality of life. They have a strongly ascend-
ing prevalence. Chronic obstructive pulmonary dis-
ease (COPD) is currently the most common chronic 
lung disease and presents a serious medical, eco-
nomic, and social problem for the human population.
COPD affects 210 million people the world 
over. It is a disease of civilization from which 
about three million people worldwide die annu-
ally. It is a global health problem and the increas-
ingly fourth-leading cause of death among diseases 
worldwide. The World Health Organization (WHO) 
predicts that by 2030, the disease will reach third 
place (WHO, 2007; Drugdová, 2011). According 
to a pneumological statement of the NCHI (2012), 
in Slovakia alone, around 42,000 people have been 
recorded as having asthma and nearly 53,000 peo-
ple as having COPD (GOLD 2007, 2011).
According to the ATS/ERS (2013), pulmonary 
rehabilitation is a multidisciplinary and comprehen-
sive form of intervention for patients with chronic lung 
disease in which symptoms predominate and often 
limit daily activities. It is part of an individual patient’s 
treatment and is designed to optimize their function-
al status, improve their participation in physical and 
social activities, improve the quality of life, and reduce 
health care costs through stabilizing or reversing sys-
temic manifestations of the disease (Spruit, 2013).
Chronic obstructive pulmonary disease (COPD) 
is a disease defined as an airway passage obstruction 
that is not fully reversible. Bronchial obstruction 
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is progressive and is associated with the abnormal 
inflammatory response of lungs to noxious particles 
or gases (GOLD 2007, GOLD 2011, 2013, Rabe 
et al. 2007). This disease is now one of the leading 
causes of chronic morbidity and mortality (Raherison 
& Girodet 2009). It is characterized as a progressive 
disease and a highly irreversible obstruction associ-
ated with dyspnoea (Celli 2008). Patients suffering 
from COPD face a condition of existence defined by 
performance impairment in everyday activities and 
reliance on long-term oxygen therapy (Niewoehner 
2010), with limited functional ability and a significant 
psychosocial burden. Research suggests that patients 
with COPD have a high incidence of anxiety and 
depression, which has a significant negative impact 
on their morbidity and quality of life (Ng et al. 2007).
Given the complexity of clinical conditions and 
comorbidities, the treatment of COPD is complex 
and multidisciplinary. The therapy of mild to mod-
erate COPD is based on the elimination of risk fac-
tors. An important part of complex COPD treatment 
according to the GOLD criteria is pulmonary reha-
bilitation, which is indicated from COPD, Stage 2. 
It focuses on the range of extra-pulmonary problems 
that cannot be adequately addressed through medi-
cal therapy (GOLD 2013, Kubincová et al. 2011).
According to the definition of the WHO (2001, 
2007), quality of life means how one perceives his/
her position in life in the context of the culture he/she 
lives in and in relation to his/her goals, expectations, 
lifestyle, and interests. Physical health, psychologi-
cal condition, level of independence, social relation-
ships, and the ecological characteristics of the envi-
ronment affect the above-defined individual quality 
of life. Since the second half of the twentieth cen-
tury, the concept of quality of life has been emerg-
ing and explored in various scientific disciplines. 
The material aspects of society’s life as a whole 
stood at the centre of focus from the very beginning, 
but later we can observe a gradually strengthening 
movement towards non-materialistic aspects and a 
shift to the subjective perception and assessment of 
the quality of life in individuals (WHO 2007). The 
most frequently used generic questionnaire is the 
Short Form 36 Health Questionnaire (SF-36). This 
instrument was generally used for measuring health 
status and health-related QOL. Thanks to its high 
informative, value this questionnaire is often used 
to assess personal health condition in various fields 
of medicine (Řehulková 2008).
Quality of life is the important result of the 
measurement of pulmonary rehabilitation. 
The quality of life of 166 patients with COPD 
was examined at the Pulmonary Department in 
Prague. The researchers compared patients receiv-
ing long-term home oxygen therapy treatment for 
severe COPD with a group of healthy respondents. 
The standardized questionnaire SF-36 was used 
to evaluate the results. The researchers assessed 
the quality of life in the following areas: physi-
cal activity, general feeling of health, vitality, and 
social activity. The average age of patients in the 
first group was 62.5 years. The greatest differences 
were reported in the assessment of physical activity 
and limitations in patients with COPD treated with 
home oxygen therapy (22.8 and 9.8) compared to 
healthy respondents (94.1 and 86.4). The quality of 
life varied primarily in the area of physical activ-
ity, the general feeling of health and social activity 
(p<0.001). The examinations were supplemented 
with spirometry tests and the correlation revealed 
that low values of the questionnaire scores were 
also accompanied by low FEV 1 values in the group 
of patients with COPD treated with home oxygen 
therapy, while the scores were high in the group of 
healthy individuals (Vondra & Malý 2003). 
In his study, Leupoldt (2008) examined 210 
patients with COPD and investigated the effects 
of intensive 3-week outpatient pulmonary rehabili-
tation aimed at training lung capacity, dyspnoea 
and improving the quality of life. The examina-
tions were carried out before and after pulmonary 
rehabilitation and were aimed at evaluating physi-
cal activity with a 6-minute walking test (6MWT); 
dyspnoea was measured after the 6MWT on the 
Borg effort scale and, quality of life was observed 
by means of the SF-36 test. The results indicated 
an improvement in the 6MWT (+39 m, p < 0.001) 
after the treatment and at the same time reduced 
dyspnoea with the 6MWT (-0.5, p < 0.001). The 
improvement in all SF-36 dimensions reflects a 
better quality of life after treatment (p < 0.001). 
Fritzsche (2013) points out in his study that 
depression and other related negatives in the course 
of a disease are highly prevalent comorbidities in 
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patients with COPD. These factors significantly con-
tribute to the social and economic burden on patients. 
The quality of life in patients with COPD is influ-
enced not only by symptoms, but also by comorbidi-
ties, the severity of the disease, and other impacts 
that have to be further examined and evaluated.
Female patients with COPD experience sig-
nificantly more psychological distress than male 
patients, which can be explained by the wrongly 
understood control of symptoms, especially dys-
pnoea. Dyspnoea, in combination with little activ-
ity, poor physical condition, and functional impair-
ment, contributes to the development of anxiety 
and depression (Coventry ,2011; Di Marco,2006). 
According to Qaseem et al. (2011), psycho-
social interventions for patients should include an 
assessment of disability, expert advice, as well as 
patient and family education. In addition, psycho-
logical support can ease the adjustment process 
by supporting adaptive thinking and behaviour – 
coping strategies that help patients to reduce their 
negative emotions, which can improve compliance 
with rehabilitation programs. Psychological support 
helps in overcoming addictions, especially smoking. 
TheA study by Maurer (2008) shows that the qual-
ity of life in patients with respiratory diseases is fur-
ther aggravated by comorbidities including depression, 
depressive symptoms, and anxiety. The researchers 
found that depressive symptoms were more common 
with COPD than with coronary heart disease, stroke, 
diabetes mellitus, arthritis, or hypertension. Forty per-
cent of patients showed at least three symptoms of 
depression. Another study determined that the risk of 
depression is 2.5 times higher in patients with severe 
COPD than in a control group of patients without 
COPD or with bronchial asthma. The authors con-
cluded that there is an increased risk of depression in 
patients with severe COPD, and the results highlight 
the importance of reducing symptoms and improving 
the physical functioning of patients with COPD.
AIMS AND METHODS 
The main goal of the research was to determine 
the impact of the symptoms of COPD on the qual-
ity of life in patients with the disease. 
The research sample consisted of 80 respon-
dents aged 40 to 88 years. The average age of our 
respondents was 61.9 years, SD ± 15.0. Both gen-
ders were represented in the sample, with 38 men 
(48%) and 42 women (52%). 
Sixty-three respondents (49.2%) were non-
smokers. In the past, 49 (38.3%) respondents were 
smokers, and 16 (12.5%) respondents also smoked 
during the treatment. In the past respondents had 
smoked minimally 3 and maximally 80 cigarettes 
per day, with an average of 19 cigarettes a day. 
Currently smoking respondents smoked at least 5 
and at most 20 cigarettes per day, with a daily aver-
age of 7.8 cigarettes.
All respondents were patients with COPD being 
treated at lung clinics in Bardejov, in the Slovak 
Republic. The study was conducted between 
September 2011 and March 2012. 
The research data were processed using the 
method of descriptive statistics, Pearson’s correla-
tion coefficient, regression analysis, and the t-test.
We used standardised questionnaires as our 
research method to assess the quality of life in 
patients suffering from COPD: the SF-36 quality-
of-life questionnaire and the SGRQ questionnaire; 
we wanted to prove that symptoms affect the qual-
ity of life in patients with COPD.
The SF-36 is a multi-purpose, short-form health 
survey with only 36 questions. It yields an eight-
scale profile of functional-health and well-being 
scores as well as psychometrically-based physi-
cal and mental health summary measures and a 
preference-based health utility index. It is a generic 
measure, as opposed to one that targets a specific 
age, disease, or treatment group. Accordingly, the 
SF-36 has proven useful in surveys of general and 
specific populations, comparing the relative bur-
den of diseases, and in differentiating the health 
benefits produced by a wide range of different 
treatments. Overall physical health clusters the fol-
lowing areas: physical activity, physical activity 
limitation (“role – physical”), physical pain, and 
general health assessment. Overall mental health 
aggregates the following areas: vitality, social 
activity, limitation by emotional problems (“role 
– emotional”) and mental health. A score ranging 
from 0 to 100, on which a higher score indicating 
a more favourable condition can be determined for 
each dimension (Ware, 2001, 2004). 
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Saint George’s Respiratory Questionnaire 
(SGRQ) has been designed to measure the quality of 
life in patients with COPD. The questionnaire consists 
of two parts. The first part examines symptoms in 
patients for the last preceding period, and the second 
part examines the current condition of a patient, his/
her activities, and impacts (activities) of the disease. 
Three components are assessed under this question-
naire. The first component, the symptoms score, 
shows the frequency and severity of respiratory 
problems, such as coughing, dyspnoea, the number 
and severity of spasms. The activity score relates to 
activities limited by dyspnoea. The score of the impact 
shows those aspects associated with social functioning 
and psychological disorder resulting from respiratory 
disease. The total score is calculated in the last step 
to sum up the impacts of the disease on the overall 
health of patients. Each answer is assigned a number 
ranging from 0 to 100, with 100 being the worst pos-
sible health condition and 0 being the best condition. 
The worst possible score for symptoms is 662.5; for 
activity 1209.1; for impacts (effects) of the disease 
2117.8 and the worst total score is 3989.4 The score is 
100 times the “Summed weights from positive items 
in the questionnaire” divided by the “sum of weights 
for all items in the questionnaire” (Jones 2009). 
RESULTS AND DISCUSSION
Patients with chronic obstructive pulmonary 
disease have a slightly reduced quality of life in 
the following dimensions: role – physical, bodily 
pain, role – emotional and social functioning. In 
areas such as general health, physical functioning, 
mental health and vitality, patients rated their qual-
ity of life as lower than average (tab.1).








General Health 39.85 21.42
Physical Functioning 44.625 29.23
Role – Physical 80.147 43.09
Bodily Pain 55.687 23.14
Vitality 38.625 19.29
Social Functioning 52.187 30.925
Role – emotional 53.333 44.878
Mental Health 48.40 23.673
In the evaluation of quality of life using the 
SGRQ, a reduced quality of life was found in all three 
dimensions: symptoms, activity and impacts (tab. 2). 












Table 3 shows correlations between quality of 
life in patients with COPD measured by the SF-36 
questionnaire and symptoms dimension from the 
SGRQ questionnaire, regardless of gender. 
A strong correlation was observed between the 
dimensions “role – emotional” (i.e., limitation by 
emotional problems) and “symptoms” – r = -0.709, 
(p<0.005), as well as between the dimension enti-
tled “role – physical” (i.e., physical activity limita-
tion) and “symptoms” – r = -0.676 (p<0.005).
Moderate correlations were found between 
symptoms and bodily pain (r = -0.586), vitality 
(r = -0.572), social functioning (r = -0.435) and 
mental health (r = -0.487), with p < 0.005.
Since the SF-36 questionnaire covers the val-
ues from 0 to 100 with a higher score indicating 
a more favourable condition, we can confirm that 
individual dimensions such as general health (r = 
-0.632), physical functioning (r = -0.650), p<0.05, 
as well as all other individual dimensions, wors-
ened with the increasing symptom score.
The results of regression analysis show that the vari-
ables are linearly dependent: the symptoms do affect the 
quality of life of patients with COPD (p<0.05). 
The absolute value of the correlation coefficient 
for general health is r = 0.63, for physical func-
tioning r = 0.58, for role – physical r = 0.35, for 
bodily pain r = 0.72, for vitality r = 0.68, for social 
functioning r = 0.62, for role – emotional r = 0.47 
and for mental health r = 0.68. 
The coefficient of determination r2 = 0.53 shows 
that 53% of the variability of symptoms is in linear 
relations with bodily pain, 47% with vitality, and 
46% with mental health (see Table 4).
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For evaluating gender comparisons with SGRQ 
domains, we processed the results using the statisti-
cal t-test for two independent samples.
Table 5 shows the gender comparison with 
the following domains: symptoms, activity, and 
impacts. It demonstrates that the value of statisti-
cal significance is p ˃ 0.05, so we do not observe a 
statistically significant difference between the gen-
ders. The statistical significance value for symp-
toms is represented by 0.712, activity by 0.275, and 
for impacts by 0.255. The standard deviations are 
also slightly different.
CONCLUSION 
The quality of life in patients with COPD may 
be adversely affected by a number of different 
signs and airway obstruction symptoms. The pres-
ence of symptoms or fear of them in patients with 
COPD causes the impairment of physical activities 
or social situations from which they would oth-
erwise have derived pleasure. The results of the 
SF-36 questionnaire indicated that the health-relat-
ed quality of life was mostly limited with respect 
to general health, physical functioning, vitality 
and mental health. By the worsening of symptoms 
such as cough and dyspnoea, the patients reported 
a worsening of the general health, physical func-
tioning, bodily pain, vitality, social functioning 
and mental health. A strong linear relationship was 
observed between the symptoms and the dimen-
sion entitled role – emotional (i.e., limitation by 
emotional problems). A survey of patients found 
that they focus on feeling unwell, their ability to 
perform everyday activities and on the emotional 
consequences of the disease. Doctors, on the other 
hand, focus on physical functions and measuring 
clinical symptoms. For many people with COPD, 
experience in caring includes a reactive approach to 
physical symptoms and acute exacerbations. This 
often leads to the neglect of psychosocial prob-
lems and inappropriate management strategies. It 
is essential that healthcare professionals understand 
and address these psychological aspects of the dis-
ease so that patients and carriers can be supported 
to live with their disease.
A limitation of the study was the absence of 
a control group and the examination of present 
comorbidities in patients suffering from COPD.
The author(s) declare that they have no conflict 
of interests.









General Health -0.632 0.000
Physical Functioning -0.650 0.000
Role – Physical -0.676 0.000
Bodily Pain -0.586 0.000
Vitality -0.572 0.000
Social Functioning -0.435 0.000
Role – emotional -0.709 0.000
Mental Health -0.487 0.000
Table 4. Regression analysis – the predictor is 




Multi R R Square p value
General Health 0.63 0.39 0.000
Physical Functioning 0.58 0.34 0.000
Role – Physical 0.35 0.12 0.000
Bodily Pain 0.72 0.53 0.000
Vitality 0.68 0.47 0.000
Social Functioning 0.62 0.38 0.000
Role – emotional 0.47 0.22 0.000
Mental Health 0.68 0.46 0.000
Table 5. Gender differences in SGRQ domains
SGRQ 
questionnaire 
Gender N arithmetic 
mean
t p value
Symptoms Man 38 54.69 0.370 0.712
Woman 42 52.97
Activity Man 38 69.12 0.099 0.275
Woman 42 64.68
Impacts Man 38 57.79 1.147 0.255
Woman 42 50.31
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KVALITETA ŽIVOTA OSOBA S KRONIČNOM 
OPSTRUKTIVNOM PLUĆNOM BOLEŠĆU
Sažetak: Cilj istraživanja bio je utvrditi utjecaj simptoma na individualne dimenzije kvalitete života u bolesnika s kroničnom 
opstruktivnom plućnom bolešću (KOPB).
Prisutnost simptoma ili strah od njih kod osoba koje boluju od KOPB-a utječe na njihove fizičke i socijalne aktivnosti. Aktivno 
suprotstavljanje bolesti umanjuje fizičke, emocionalne i financijske resurse osobe i utječe na pacijentovu sposobnost prevladavanja 
drugih životnih situacija.
Uzorak ispitanika u ovom istraživanju sastojao se od 80 osoba s KOPB-om, II stupanj po GOLD klasifikaciji. Prosječna dob 
ispitanika bila je 62.9 godina. Ispitivanje je provedeno primjenom kratke forme Upitnika o kvaliteti života SF-36 te upitnika SGRQ.
Rezultati ispitanika na upitniku SF-36 pokazali su da je uslijed bolesti kvaliteta njihova života bila smanjena – sniženi rezultati 
bili su prisutni na dimenzijama općeg zdravlja, fizičkog funkcioniranja, vitalnosti i mentalnog zdravlja. S pogoršanjem simptoma 
bolesti, poput kašlja i dispneje, ispitanici su iskazali pogoršanje u odnosu na sljedeće dimenzije: opće zdravlje, fizičko funkcioniranje, 
tjelesna bol, vitalnost, socijalno funkcioniranje i mentalno zdravlje. Snažna linearna povezanost pokazala se između simptoma 
bolesti i ograničenja koja osoba trpi uslijed emocionalnih problema.
Cilj sveobuhvatne terapije KOPB-a trebao bi biti ublažavanje simptoma, sprječavanje gubitka kompetencija, pospješivanje 
dnevnih aktivnosti i opće poboljšanje kvalitete života osoba koje boluju od ove kronične bolesti.
Ključne riječi: Kronični opstruktivni bronhitis, kvaliteta života, respiratorna fizioterapija
